Description: Taj Pharmaceuticals is a privately-owned pharmaceutical company which was established as a knowledge-based firm in 1985. Taj Pharmaceuticals strategic and customer-focused approach to developing, producing and marketing high-quality affordable medicines has successfully made us one of the first respected generic companies (which develop high-tech medicines) in India. Collaboration, innovation and scientific excellence are Taj Pharma’s main principles. Taj Pharmaceuticals is one of Taj Pharma Group industrial group subsidiaries. Taj Pharma Group consists of nearly 21 subsidiaries, operating in regional, national and international levels, more than 30 Manufacturing sites, 60 product groups, $1 billion annual turnover and approximately 29,500 employees. Taj Pharmaceuticals Technology Taj Pharmaceuticals focus on novel drug delivery systems (NDDS) technology. Taj Pharma has been doing systematic research into injectable controlled release medicine especially peptides and proteins. Taj Pharma’s Clinical applications of controlled-release drug delivery in our technology is based on biodegradable in-situ forming gel depots in which a bio-therapeutic agents encapsulated in the polylactide-co-glycolide (PLGA)-based materials. In order to avoid inconvenient surgical insertion of large implants, injectable biodegradable and biocompatible polymeric particles could be employed for controlled drug delivery. In-situ forming semisolid depots are injected as liquids by needle in gauge 21 and then undergo a phase transition to a semisolid gel at the site of injection to form the drug-releasing depot. The controlled release of bioactive macromolecules via our technology has a number of advantages such as ease of administration, more patient compliance, less complicated fabrication, and less stressful manufacturing conditions for sensitive drug molecules. Taj Pharmaceuticals is the second manufacturer of this high-tech medicine (Injectable In-situ Forming Implant) in the world. We have four High- tech products available as follows: • Triprorelin 3.75 (Triprorelin acetate, for SC injection ,One Month Depot) • Triptoreline 11.25 (Triprorelin acetate, for SC injection ,Three Month Depot) • Leuproreline 3.75 (Leuproreline acetate, for SC injection, One Month Depot) • Leuproreline 7.5 (Leuproreline acetate, for SC injection, One Month Depot) Taj Pharma Other products are available as follows: • ZoledronicTaj 4 mg (Zoledronic Acid for IV infusion ) • Variomitexan 400 Mg (Mesna, for IV infusion ) • Acetaminophon 1 (Acetaminophon for IV infuision ) • Tab Metofor XR1000/500 mg (Extended Release-Metformin) • Tab Sitataj 1000+50/500+50 (Metformin+Sitagliptin) Taj Pharma has three High-tech products in our pipe-line: • Leuproreline 11.25 (Leuproreline acetate, for SC injection, Three Month Depot) • Octrotide 20 (One month) • Buprenophine (One month) Taj Pharma has Diabetes products available as follow: • Tab Sitagliptin 100/50/25 (Sitagliptin) Quality of Taj Pharma products: All the quality controlled tests like in-vitro test, release profile, animal study, bioequivalence and clinical trials have been done. Their results proved phenomenal quality. Taj Pharma Research facilities: Taj Pharma’s R&D laboratories are located in Vapi, Gujarat, India. Taj Pharma has all the essential pharmaceutical laboratory equipment and access to Laboratories of spectroscopic analysis (IR, NMR and UV), thermal behavior, physical and mechanical properties evaluation, environmental stability evaluation, coatings property evaluation, X-ray diffraction, optical and electronic microscopies, rheology, chromatography and in vivo/in vitro tests are some of representative centers for property evaluation of Novel Drug Delivery systems.
Dimensions: 1600 x 1200
File Type: png
File Size: 1 MB
